within Pharmacolibrary.Drugs.C_CardiovascularSystem.C09B_AceInhibitorsCombinations.C09BA04_PerindoprilAndDiuretics;

model PerindoprilAndDiuretics
  extends Pharmacolibrary.Drugs.ATC.C.C09BA04;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>C09BA04</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Perindopril and diuretics (such as indapamide) is a fixed-dose combination therapy used primarily for the treatment of hypertension and heart failure. Perindopril is an angiotensin-converting enzyme (ACE) inhibitor that acts to lower blood pressure by inhibiting the renin-angiotensin-aldosterone system, while the diuretic component increases urinary excretion of sodium and water, further reducing blood pressure. This combination therapy is approved and widely used in current clinical practice.</p><h4>Pharmacokinetics</h4><p>Typical pharmacokinetic parameters for perindopril and indapamide combination in healthy adult subjects; parameters are estimated from publicly available sources for perindopril in combination with a thiazide-like diuretic (e.g., indapamide) as limited data for the fixed-dose combination are available.</p><h4>References</h4><ol><li><p>Macfadyen, RJ, et al., &amp; Reid, JL (1990). Perindopril. A review of its pharmacokinetics and clinical pharmacology. <i>Drugs</i> 39 Suppl 1 49–63. DOI:<a href=\"https://doi.org/10.2165/00003495-199000391-00009\">10.2165/00003495-199000391-00009</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/2407493/\">https://pubmed.ncbi.nlm.nih.gov/2407493</a></p></li><li><p>Vandenburg, MJ, et al., &amp; Desche, P (1993). Digoxin pharmacokinetics and perindopril in heart failure patients. <i>Journal of clinical pharmacology</i> 33(2) 146–149. DOI:<a href=\"https://doi.org/10.1002/j.1552-4604.1993.tb03935.x\">10.1002/j.1552-4604.1993.tb03935.x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/8440763/\">https://pubmed.ncbi.nlm.nih.gov/8440763</a></p></li><li><p>Ogawa, R, et al., &amp; Echizen, H (2014). Clinical pharmacokinetics of drugs in patients with heart failure: an update (part 2, drugs administered orally). <i>Clinical pharmacokinetics</i> 53(12) 1083–1114. DOI:<a href=\"https://doi.org/10.1007/s40262-014-0189-3\">10.1007/s40262-014-0189-3</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/25248847/\">https://pubmed.ncbi.nlm.nih.gov/25248847</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end PerindoprilAndDiuretics;
